Financhill
Sell
42

DBD Quote, Financials, Valuation and Earnings

Last price:
$44.18
Seasonality move :
22.4%
Day range:
$43.22 - $43.98
52-week range:
$30.37 - $51.81
Dividend yield:
0%
P/E ratio:
356.62x
P/S ratio:
0.44x
P/B ratio:
1.78x
Volume:
88.3K
Avg. volume:
137.1K
1-year change:
25.37%
Market cap:
$1.7B
Revenue:
$3.8B
EPS (TTM):
-$0.44

Earnings Data

Next earnings date for DBD
May 02
2025
Most recent earnings per share
$0.15
Missed by $0.91
(Feb 12/2025)
Consensus Estimate
$1.06
(Feb 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

DBD Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/02/2025 Q1 $846M -- -- $0.43 --
02/12/2025 Q4 $988M $988.9M $0.15 $1.06 -$0.91
11/07/2024 Q3 $929.5M $927.1M -$0.60 $1.14 -$1.74
08/07/2024 Q2 $913.5M $939.7M $0.40 $1.05 -$0.65
05/02/2024 Q1 $875.7M $895.4M -$0.39 $0.23 -$0.62
02/14/2024 Q4 $1B -- $0.72 $1.43 -$0.71
11/09/2023 Q3 $946M -- -- $0.81 --
06/30/2023 Q2 $919.4M $922.2M -$8.46 -- --
03/31/2023 Q1 $875.2M $858.1M -$1.40 -- --
12/31/2022 Q4 $981.3M $968.8M -$1.89 -- --
09/30/2022 Q3 $843.6M $810.4M -$0.63 -- --
06/30/2022 Q2 -- $851.7M -$2.52 -- --
03/31/2022 Q1 -- $829.8M -$2.33 -- --
12/31/2021 Q4 -- $1.1B -$0.49 -- --
09/30/2021 Q3 -- $958.2M -$0.03 -- --
06/30/2021 Q2 -- $943.5M -$0.39 -- --
03/31/2021 Q1 -- $943.9M -$0.10 -- --
12/31/2020 Q4 -- $1.1B -$0.66 -- --
09/30/2020 Q3 -- $995.2M -$1.31 -- --
06/30/2020 Q2 -- $890.5M -$0.31 -- --
03/31/2020 Q1 -- $910.7M -$1.20 -- --
12/31/2019 Q4 -- $1.2B -$1.60 -- --
09/30/2019 Q3 -- $1.1B -$0.46 -- --
06/30/2019 Q2 -- $1.2B -$0.66 -- --
03/31/2019 Q1 -- $1B -$1.74 -- --
12/31/2018 Q4 -- $1.3B -$1.62 -- --
09/30/2018 Q3 -- $1.1B -$3.13 -- --
06/30/2018 Q2 -- $1.1B -$1.76 -- --
03/31/2018 Q1 -- $1.1B -$0.97 -- --
12/31/2017 Q4 -- $1.2B -$1.43 -- --
09/30/2017 Q3 -- $1.1B -$0.48 -- --
06/30/2017 Q2 -- $1.1B -$0.41 -- --
03/31/2017 Q1 -- $1.1B -$0.78 -- --
12/31/2016 Q4 -- $1.2B -$1.04 -- --
09/30/2016 Q3 -- $983.3M -$1.44 -- --
06/30/2016 Q2 -- $580M -$0.32 -- --
03/31/2016 Q1 -- $509.6M $2.56 -- --
12/31/2015 Q4 -- $610.4M $0.54 -- --
09/30/2015 Q3 -- $589.6M $0.33 -- --
06/30/2015 Q2 -- $644.5M $0.34 -- --
03/31/2015 Q1 -- $574.8M -$0.04 -- --

Diebold Nixdorf Earnings Questions

  • How Much did Diebold Nixdorf Generate in Revenue Last Quarter?

    Diebold Nixdorf reported $988.9M worth of top line sales in its most recent quarter.

  • Did Diebold Nixdorf Beat Earnings Last Quarter?

    Diebold Nixdorf announced earnings per share of $0.15 which represents a miss of analyst forecast a $1.06 per share.

  • Is Diebold Nixdorf Profitable?

    Diebold Nixdorf reported $231.6M that represents $6.16 per share over the last quarter.

  • What is the Analyst Consensus for Diebold Nixdorf EPS Next Year?

    Diebold Nixdorf's earnings are forecast to decrease from -$0.44 per share to $3.72 per share next year representing a decrease of -71.88%.

  • When is Diebold Nixdorf's Earnings Date?

    Diebold Nixdorf's next earnings date is May 2, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Sell
49
SRPT alert for Mar 19

Sarepta Therapeutics [SRPT] is up 8.01% over the past day.

Sell
46
CVNA alert for Mar 19

Carvana [CVNA] is up 3.8% over the past day.

Buy
93
ESLT alert for Mar 19

Elbit Systems [ESLT] is down 0.5% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock